Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Phase I data reveal protective effects for MnSOD-PL in chemoradiotherapy-treated NSCLC

April 1, 2011

Composite iMyD88/CD40 fusion protein shows enhanced antitumor activity

March 31, 2011

Natco Pharma receives FDA orphan drug status for NRC-AN-019

March 31, 2011

Amgen and Takeda report topline phase II results for motesanib in lung cancer

March 31, 2011

Merck Serono applies for E.U. indication extension for Erbitux for advanced or metastatic NSCLC

March 31, 2011

Phase II trial compares MDV-3100 with bicalutamide in advanced prostate cancer

March 31, 2011

Gilead Sciences and Yale to collaborate on cancer research

March 31, 2011

Ark Therapeutics presents new neuropilin-1 antagonists

March 31, 2011

New steroid sulfatase/aromatase inhibitors reported by Sterix

March 31, 2011

SMO inhibitors reported by Pfizer for use in cancer

March 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...